Business Wire

EVER Pharma Launches the User-friendly D-mine® Pump Generated Report “DATA-mine®” to Enhance the Therapy Management of Parkinson’s Patients on Apomorphine

Share

After successfully launching the D-mine ® Pump, a micro infusion device designed to provide precise continuous subcutaneous drug delivery for PD patients, the product family has been extended to include a comprehensive data history readout.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005029/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The user-friendly DATA-mine® REPORT (Graphic: Business Wire)

EVER Pharma, a specialist in neurology and specialty pharmaceuticals, offers a complete therapy package for PD patients with Dacepton® (Dopaceptin®, Apomorphine hydrochloride), D-mine® Pump, D-mine ® Pen and now the DATA-mine® REPORT, a tool to read out the data of the D-mine ® Pump.

Through this tool the D-mine ® Pump history file can be easily transformed into a handy report in PDF format, on Windows or macOS devices allowing Healthcare Professionals to navigate through the various parameters of the infusion therapy like dosing, flow rates, and time settings in easy-to-read tables and graphs and adapt it accordingly.

“With the DATA-mine ® REPORT, we continue to optimize our product offering by ensuring the best possible therapy management of Parkinson’s patients on Apomorphine and facilitating the follow up of the Healthcare Professional”, explains Georges Kahwati, General Manager at EVER Pharma GmbH.

For more information please visit www.d-minecare.com.

About EVER Pharma GmbH
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialization of products in the areas of neurology, critical care, anesthesia and oncology.

From global headquarters in Austria it runs a dynamic operation providing innovative therapies and value-added formulations aimed at enhancing patient and healthcare professional’s lives through improved safety and convenience.

The products are developed and manufactured at EU GMP certified facilities in Austria and Germany. The technical operations are highly specialized in the production of complex injectables including high potency substances, crystal suspensions, oily solutions and controlled substances in vials, pre-filled syringes, cartridges, ampoules and implants. EVER markets its products in more than 80 countries around the world through 30 international affiliated companies and strategic partners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press
Marie-Kristin Schöppl
International Marketing Manager
Phone: +43 7665 20555 530
E-Mail: marie-kristin.schoeppl@everpharma.com
www.everpharma.com
www.d-minecare.com

Partner/Investor Relations
Dominic Benning
Head of Dopaminergic Therapy
Phone: +43 7665 20555 861
E-Mail: dominic.benning@everpharma.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF to Webcast 2022 Investor Day Presentations on December 729.11.2022 00:15:00 EET | Press release

IFF (NYSE:IFF) today announced that it will webcast its 2022 Investor Day presentation on Wednesday, Dec. 7, 2022, beginning at 1:00 p.m. ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn. View source version on businesswire.com: https://www.b

Megaport Adds Cloud and Networking Sales Veteran Jeff Tworek to the Executive Team as Chief Revenue Officer29.11.2022 00:00:00 EET | Press release

Megaport​ (ASX: MP1), a leading global Network as a Service (NaaS) provider, announced today the addition of Jeff Tworek to the executive team as Chief Revenue Officer. Tworek will be responsible for overall revenue generation and will manage all aspects of Megaport’s global sales organisation. Mr Tworek brings more than 30 years of cloud and networking industry experience operating commercial business units within billion-dollar companies, including nearly 20 years at Akamai Technologies, to Megaport. Prior to joining the Company, Mr Tworek held the CRO position at Contrast Security, where he helped the company scale its teams, bring in key leadership, and prepare the company for growth. He brings a wealth of high growth and expansion-related expertise from his time spent at both start-ups and large, established organizations. “We are delighted to welcome Jeff to the team,” said Vincent English, Chief Executive Officer, Megaport. “Jeff’s experience with leading and transforming global

AGCO Agriculture Foundation Donates to UK's Biggest Charity Fighting Hunger and Tackling Food Waste28.11.2022 22:52:00 EET | Press release

The AGCO Agriculture Foundation (AAF), a private foundation with the vision to prevent and relieve hunger through sustainable agricultural development, today announced a USD 300,000 grant to FareShare to ensure surplus food reaches vulnerable communities in the United Kingdom while tackling food waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005695/en/ AAF grant to FareShare to secure 475 tonnes of surplus food. (Photo: Business Wire) The two-year partnership is expected to help FareShare secure 475 tonnes of surplus food and redistribute more than one million meals. The project will assist in growing the award-winning Surplus with Purpose Fund, which covers the cost for farmers to harvest and divert food that would have otherwise been wasted. The Intergovernmental Panel on Climate Change estimates that food waste contributes between 8 and 10 percent of global greenhouse gas emissions, so tackling food waste is

Quantfury Introduces Fractional Trading Mode for Stocks, ETFs and Commodities28.11.2022 21:00:00 EET | Press release

Quantfury Trading Limited (“Quantfury”), a global brokerage firm that delivers commission-free trading and investing at real-time spot prices of global and crypto exchanges, today announced the launch of fractional trading mode with more than 1500+ stocks, ETFs and commodity futures contracts available to trade on the Quantfury platform. Quantfurians can now buy and sell fractional shares of all stocks, ETFs and commodity futures contracts at their real-time US and European exchanges spot prices with zero commissions and borrowing fees, providing improved trading and investment experience. “Quantfury is advancing its unmatched trading and investing conditions further by making it even more affordable to Quantfurians out there,” said Daniel Muvdi, Quantfury’s Head of Markets. “Fractional trading mode opens up more trading opportunities to the Quantfury global audience of more than 400,000 Quantfurians.” Fractional trading mode is available on all Quantfury trading platforms immediately,

The 4th World Science and Technology Development Forum Held in Chengdu28.11.2022 19:06:00 EET | Press release

The 4th World Science and Technology Development Forum with the theme “Openness, Trust and Cooperation” kicked off in Chengdu on November 27, 2022, which was attended by more than 300 top experts and scholars, representatives of international organizations, and entrepreneurs, from more than 20 countries and regions, including 7 Nobel laureates and more than 60 academicians home and abroad. Together, they discussed technological innovation and sustainable development in key fields such as basic science, climate change, digital economy, and green innovation, and proposed technological innovation solutions to address the challenges of today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005539/en/ The 4th World Science and Technology Development Forum Held in Chengdu (Photo: Business Wire) The world today is facing many challenges, such as the COVID-19 pandemic, energy security, food security, climate change, poverty, an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom